Reglan FDA Warns Of Neurological Disorder Linked To Reflux Drug Reglan The U.S. Food and Drug Administration has ordered the makers of the acid reflux medication Reglan to include a black box warning -- the strongest labeling the FDA can order against a drug. The reason: the drug may lead to a serious condition known as tardive dyskinesia after chronic or high-dosage use. People with tardive dyskinesia experience involuntary, repetitive and purposeless movements. Features include grimacing, lip smacking, puckering or pursing of the lips, rapid eye blinking, rapid movement of extremities, and impaired movement of the fingers.

If you or a loved one has developed tardive dyskinesia as a result of the long-term use of Reglan, you need to contact the experienced drug injury lawyers at Lerner & Rowe, P.C., by calling (602) 977-1900. We can explain your legal options and if you have a valid case, we'll work tirelessly to help you recover money damages for the harm you've suffered. Reglan is the brand name for the drug metoclopramide, prescribed to more than 2 million Americans for gastroesophageal reflux disease, diabetic gastroparesis and delayed gastric diseases. Metoclopramide works by speeding up the movement of the stomach muscles, increasing the rate at which the stomach empties into the intestines. Reglan is available in tablets, syrups and injections.

Names include Reglan Tablets, Reglan Oral Disintegrating Tablets, Metoclopramide Oral Solution, and Reglan Injection. Reglan is recommended only for up to three months of use, but one in every five users takes it for longer periods because of the chronic nature of the conditions that the drug treats. Tardive dyskinesia is a syndrome of jerky, involuntary movements that often affects the tongue, face, mouth or jaw. Dyskinesia refers to the jerky, involuntary movements themselves, while tardive means the jerky movements can continue even after people stop using the medication.

Recent studies suggest that long-term Reglan use is the most common cause of drug-induced movement disorders, according to the FDA. A black box warning means a drug carries a significant risk of serious or even life-threatening adverse effects. In ordering the warning for Reglan, the FDA told the drug's makers to develop a risk evaluation and mitigation strategy that will require them to provide a detailed medication guide for users. Lerner & Rowe, P.C.,  experienced Phoenix personal injury attorneys helping victims injured by drugs and their dangerous side effects such as Reglan.

If you or a loved one has been harmed by Reglan use, call our dangerous drug hot-line at (602) 977-1900 for a FREE case evaluation